  | Today's Top Story |  |  | | - Fujifilm to acquire SonoSite for about $753 million
Fujifilm will pay about $753 million to acquire U.S. medical device firm SonoSite in an effort to strengthen its life sciences unit. Sonosite will become a unit of Fujifilm, but will continue to operate in Bothell, Wash., upon completion of the deal. Reuters (12/15)        | The Business Platinum Card® from American Express OPEN
Spending power for your business. Premium benefits for you.
Access a portfolio of 30+ premium benefits, including:
• Membership Rewards® points that pay for flights, hotels, and more
• 24/7, 1-on-1 Concierge for help with your life and your Business
• Annual $200 Airline Fee Credit for any airline
Business Platinum Card
APPLY NOW |
  - Stem cell research named top medical breakthrough of 2011
TIME Magazine has named the use of a variation of somatic cell nuclear transfer on human cells as the top medical breakthrough of the year. The work, by the New York Stem Cell Foundation, involved combining DNA from an egg cell with DNA from an adult cell. Obstacles remain, however, as the resulting stem cells contained an extra set of chromosomes. Time.com (12/7) - Scientists develop micro-sized biometric sensors
Biomedical engineers at N.C. State University, the University of California, San Diego, and Sandia National Laboratories inserted electrochemical sensors into microneedles to detect and report the presence of certain molecules in the human body. A wearable device, such as a wristwatch, could have the sensor arrays attached, researchers said. "Microneedle-based sensors could be used to monitor a variety of physiologically relevant molecules [such as] glutamate, an excitatory neurotransmitter," said N.C. State's Roger Narayan. CNET (12/14) - NIH hopes India partnership will expand affordable technologies
Biomedical cooperation between the U.S. and India will bring global benefits, such as a rotavirus vaccine, affordable technologies and advances in cancer research, NIH Director Francis Collins said. "We are looking for collaboration, innovation, opportunities for some of the best and brightest minds in India and the U.S. to find each other and work together," Collins said. ScienceMag.org/ScienceInsider (12/13)  | Effective Asset Management in an Uncertain Economy
This white paper describes 10 ways senior executives can more effectively manage their assets in an uncertain economy in order to not only avoid any damage, but more importantly, enjoy substantial improvements in productivity and profitability. Download now. |
 - ReproCell prepares to launch drug-screening technology
In the second quarter of 2012, ReproCell expects to commercialize drug-screening technology that uses hepatocytes derived from human induced pluripotent stem cells. ReproCell developed the platform with the National Institute of Biomedical Innovation in Japan. The hepatocytes express "the same qualities as that of primary human hepatocytes currently used by the pharmaceutical industry, including drug metabolizing enzyme activity," said ReproCell CEO Chikafumi Yokoyama. Genetic Engineering & Biotechnology News (12/15) 
- WEMA tests drought-tolerant maize in Kenya
A new maize variety that can grow in water-stressed environments is being tested at the Kenya Agricultural Research Institute's Kiboko Research Center as part of the Water Efficient Maize for Africa project. The Gates Foundation-funded project also involves South Africa, Uganda, Tanzania and Mozambique and aims to develop drought-resistant maize using traditional breeding and biotechnology. Coastweek.com (Kenya)/Xinhuanet.com (China) (12/16)  | Enterprise Resource Planning automates many aspects of an organization's operations, cascading across traditional boundaries of operations, finance, manufacturing and more. As such, changes in the ERP market can cause a ripple effect in your business. Get ahead of the changing tide and trends by downloading this free whitepaper. |
 | Industrial & Environmental | | | | - Mascoma, Codexis edge closer to large-scale cellulosic-biofuel output
Recent announcements from Codexis and Mascoma suggest that they are closing in on achieving commercial-scale applications of cellulosic biofuels. Mascoma has secured funding from Valero to build its cellulosic-ethanol plant in Kinross, Mich., while Codexis rolled out a new enzyme product line that will help partner Raizen convert bagasse into ethanol in Brazil. Greentech Media (12/15)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program.
| SmartQuote | | | |  | Give me the liberty to know, to utter and to argue freely according to conscience, above all liberties."
--John Milton,
British poet  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Thursday, December 15, 2011
- Wednesday, December 14, 2011
- Tuesday, December 13, 2011
- Monday, December 12, 2011
- Friday, December 09, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment